2019-12-06 15:24:12| Fool.com Headlines
Wall Street is optimistic about Teladoc's prospects. Should investors feel the same?
2019-12-06 15:00:00| Fool.com Headlines
Late-stage clinical trial results provide a chance for investors to gain significant upside from this developer of drugs combating neurological diseases.
2019-12-06 13:34:00| Fool.com Headlines
Two top competitors face off in the race for LNG stardom.
2019-12-06 12:47:00| Fool.com Headlines
Transocean has hit rock bottom. What now?
2019-12-06 12:00:00| Fool.com Headlines
These two well positioned companies look primed for a purchase.